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Cytomegalovirus Colitis in Primary
Hypogammaglobulinemia With
Normal CD4+ T Cells: Deficiency of
CMV-Specific CD8+ T Cells
Sudhanshu Agrawal, Amrita Khokhar † and Sudhir Gupta*
Program in Primary Immunodeficiency and Aging, Division of Basic and Clinical Immunology, Jeffrey Modell Diagnostic
Center for Primary Immunodeficiencies, University of California, Irvine, Irvine, CA, United States
CMV colitis has been reported in immunocompromized patients with severe deficiency of
CD4+ T cells and T cell functions. In this study we present an extensive immunological
analysis in a patient with primary hypogammaglobulinemia and CMV colitis who had
normal numbers of CD3+T, CD4+T and CD8+T cells, and normal T cell proliferative
responses to mitogens and recall antigens. Naïve (TN), central (TCM), and effector (TEM)
memory subsets of CD4+ and CD8+ T cells, Granzyme+ and Perforin+ CD8+ T cells,
PD-1+ T cells, CD4 Treg, CD8 Treg, and CMV tetramer specific CD8+ T cells were
analyzed with specific antibodies and isotype controls using multicolor flow cytometry.
CD8 TEM, Granzyme+ and Perforin+, and PD-1 CD8+T cells were increased, whereas
CD8 TN and CD8 TCM cells were decreased in the patient as compared to controls.
CMV tetramer+ CD8+ T cells were decreased in the patient. These data demonstrate
that a deficiency of CMV-specific CD8+ T cells even in the presence of normal CD4+
T cell numbers and normal T cell functions may predispose patients with primary
hypogammaglobulinemia to CMV colitis.
Keywords: PD-1, T effector memory cells, CD4 Treg, CD8 Teg, cytotoxic T cells
INTRODUCTION
Cytomegalovirus (CMV) is a double stranded DNA virus of the herpes virus family, which can
lead to a spectrum of clinical presentations, from latent infection to disseminated disease. CMV
infection has often been observed in immunocompromized patients with low CD4+ T cell counts,
and T cell functions including patients with human immunodeficiency virus infection, solid organ
or hematopoietic stem cell transplant recipients, and those on immunosuppressive agents (1–5).
Rare gastrointestinal infections with CMV have been described in patients with common variable
immunodeficiency (6–15). However, these patients had low CD4+ T cells, and in none of these
studies detailed immunological analyses, including CMV-specific CD8+ T cells were reported.
We present, to best of our knowledge, the first detailed immunological analysis in a patient with
primary hypogammaglobulinemia and CMV colitis, who has normal numbers of CD3+, CD4+,
and CD8+ T cell subsets, and normal responses to mitogens and soluble antigens. Patient displayed
a deficiency of CMV-specific CD8+ T cells, and expansion of PD-1+ exhausted CD8+ T cells.
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BACKGROUND
Case
A 39-year-old male with a past medical history significant for
hypogammaglobulinemia, and asthma, and colectomy status-
post bowel perforation, presented with several days of increasing
watery ostomy output, non-bloody vomiting, and subjective
fevers. The cause of spontaneous bowel perforation is unclear.
The diagnosis of hypogammaglobulinemia had been made 1
year prior to presentation when patient had no prior history
of any gastrointestinal symptoms. Therefore, excluding any
possibility of hypogammaglobulinemia secondary to protein-
losing enteropathy. He had been doing well on intravenous
immunoglobulin (IVIG) up until this point. A computed
tomography scan of the abdomen and pelvis with contrast
revealed diffuse small bowel mucosal hyperenhancement
consistent with enteritis, with no evidence of free air or recurrent
bowel perforation. He underwent EGD and colonoscopy with
no complications. Both procedures revealed grossly normal
mucosa with the exception of two diminutive sessile polyps at the
cecum, which were biopsied. Immunohistochemistry revealed
cells positive for cytomegalovirus and evidence of chronic active
crypt-destructive colitis related to cytomegalovirus infection.
Serum CMV was quantitated by PCR and found to be 9561
IU/ml. He was subsequently started on valgancyclovir with
marked improvement in his clinical condition. Results of routine
immunological analysis prior to starting immunoglobuline
therapy revealed IgG (498 mg/dl; control range 694–1,618
mg/dl), IgA (118 mg/dl; control range 68–378 mg/dl), IgM (92
mg/dl; control range 65–263 mg/dl). At the time of diagnosis
of CMV colitis, his lymphocyte subsets were as follow: CD3+
T cells 1,828/µl (control range 502–1,902/µl), CD4+ T-cells
949/µl (control range 338–1,194/µl), CD8+ T-cells 970/µl,
(control range 85–729/µl), CD19+ B-cells 86/µl (control range
51–473/µl), and NK cells 86/µl (range 12–349/µl). Proliferative
responses to recall antigens (Candida albicans and tetanus
toxoid) and mitogens (phytohemagglutinin, concanavalin A, and
pokeweed) were also normal. HIV was negative.
MATERIALS AND METHODS
Subjects
Peripheral blood mononuclear cells (PBMCs) were isolated from
blood of patient and healthy subject by Ficoll-hypaque density
gradient. Healthy controls were age-matched CMV antibody
positive males. The protocol was approved by the Human Subject
Committee of the Institution Review Board of the University
of California, Irvine. A written informed consent has been
obtained from the patient for the publication of this case report,
including any accompanying images or data contained within
the manuscript.
Antibodies and Reagents
CD4 PerCP, CD8 PerCP, CD45RA APC, CCR7FITC, CD183
PE, Foxp3 PE, CD170a PE, Granzyme-B FITC, Perforin FITC,
and PD-1 APC antibodies were purchased from BD Parmingen
(San Jose, California). iTAg MHC tetramer HLA-A∗0201 and
CMV PP65 Tetramer PE were obtained from MBL International
corps (Woburn MA).
Immunophenotype of Subsets of CD4+ and CD8+
T Cells
PBMNCs Cells were incubated with various monoclonal
antibodies and isotype controls for 30min at room temperature
in dark, washed, and acquired by FACSCalibur and analyzed
using Flowjo software (Treestar, Ashland, Oregon). Subsets
of CD4+ and CD8+ T cells were identified as naïve (TN):
CCR7+CD45RA+, central memory (TCM): CCR7+CD45RA-
, effector memory (TEM): CCR7-CD45RA-, and terminally
differentiated effector memory (TEMRA): CCR7-CD45RA+), and
exhausted PD-1+ CD8+ T cells.
Cytotoxic CD8+ T cells
PBMCs were activated with anti-CD3/CD28 for 24 h, and then
stained with CD8PerCP and CD107a PE for surface staining
for 30min. Cells were then fixed and permeabilize by fix perm
buffer (BD biosciences), and stained with Granzyme B-FITC and
Perforin-FITC, respectively and appropriate isotypes.
CMV Tetramer Staining
PBMCs were activated with anti-CD3/CD28, and samples were
collected at day 1 and day 4. Cells were stained with CD8 PerCP
and HLA-A∗0201 CMV PP65 Tetramer PE. After staining the
cells were washed with PBS and analyzed by FACSCalibur (BD
Biosciences, San Jose, CA) equipped with argon ion laser emitting
at 488 nm (for FITC, PE and PerCP excitation) and a spatially
separate diode laser emitting at 631 nm (for APC excitation).
Forward and side scatters were used to gate and exclude cellular
debris. Ten thousand cells were acquired and analyzed using
Flowjo software.
CD4 and CD8T Regulatory Cells
For CD4 Treg, cells were stained with CD4PerCP, CD25 FITC,
and CD127 Alexa647, and for CD8 Treg, cells were stained
with CD45RA APC, CCR7FITC, CD183 PE, according to
manufacturer’s protocol, followed by Foxp3 intracellular staining
with Foxp3 PE monoclonal antibody and an appropriate isotype
control (Mouse IgG 1k-PE) were used to evaluate nonspecific
staining and set using a Human Foxp3 Buffer Set. Staining
procedures was performed according to the manufacturer’s
recommendation. In the population of CD4+ T cells, Treg
cells were identified as CD25highCD127LowFoxp3+ cells, and in
CD8T cells Treg were identified as CD183+CCR7+CD45RA-
FoxP3+ Cells, and acquired with FACSCalibur and analyzed by
Flowjo software.
RESULTS
Altered Naïve and Memory Subsets of
CD4+ and CD8+ T Cells
CD4+ and CD8+ T cells, based upon their homing patterns,
phenotypic expression of chemokine receptors, and effector
functions have been subdivided into naïve (TN), central memory
(TCM), effector memory (TEM), and terminally differentiated
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FIGURE 1 | Subsets of CD4+ (A,B) and CD8+ (C,D) T cells. (A,C) are flow cytograph from the patient and a simultaneously analyzed healthy control. (B,D) show
individual data from 10 healthy controls and the patient. CD8 TEM cells are increased, and CD8 TN and CD8 TCM cells are decreased in the patient.
effector memory (TEMRA) subsets (16–18). Therefore, we
examined these subsets in the patient and controls. A flow
cytograph of patient and simultaneously studied control for
CD4+ T cell subset is shown in Figure 1A, and for CD8+ T cells
in Figure 1C. Individual data from 10 healthy normal control and
compared with the patient for CD4+ and CD8+ T cells subsets,
respectively are shown in Figures 1B,D. CD8+CCR7-CD45RA-
TEM were increased, whereas CD8+CCR7+CD45RA+TN and
CD8+CCD7+CD45RA- TCM cells were decreased in the patient
as compared to controls.
CD4+ T Regulatory and CD8+ T
Regulatory Cells Are Decreased
A role of CD+ Treg cells in regulating immune response
is well-established (19); however, a role of CD8+ Treg is
emerging (20). Therefore, we analyzed the proportions of
CD4+ T cells and CD8+ Treg in the patient and control.
In the patient, proportion of CD4+CD25highCD127lowFoxP3+
Treg and CD8+CCR7+CD45RA-CD183+FoxP3+Treg were
decreased as compared to CD4 Treg and CD8 Treg to healthy
controls. Figures 2A,C show flow cytographs of CD4+ Treg and
CD8+ Treg respectively, for the patient and control studied
simultaneously; Figures 2B,D show individual data for CD4 Treg
and CD8 Treg from 10 healthy controls and the patient.
Perforin and Granzyme B Positive CD8+ T
Cells Are Increased
Figure 3A show a flow cytograph from the patient and a
simultaneously studied healthy control, and Figure 3B show
individual data from 10 healthy controls and the patient. The
proportion of cytotoxic (107a+ Granzyme B +) and perforin+
CD8+ T cells were increased in the patient as compared to
controls. Figure 3C show a flow cytograph of PD-1+ CD8+ T
cells from the patient and simultaneously studied healthy control,
and Figure 3D show individual data from 10 healthy controls
and the patient. PD-1+CD8+ T cells were markedly increased
as compared to healthy control.
CMV-Specific CD8+ T Cells Are Decreased
CMV-specific tetramer + CD8T cells were analyzed at both
day 1 and day 4 following activation with anti-CD3/CD28
antibody. Figure 4A show a flow cytograph from the patient
and a simultaneously studied healthy control. At day 4, <50%
of CMV tetramer positive cells (0.035%) were present in the
patient as compared to healthy control (0.083%). A repeat CMV-
specific tetramer+ CD8T cells test 4 weeks later revealed similar
results (data not shown). Figure 4B shows individual data from
5 healthy subjects and the patient. The patient had decreased
CMV-specific CD8+ T cells.
DISCUSSION
The cytotoxic T lymphocytes (CTLs) play an important role
in defense against infection with CMV, and CMV tetramer-
specific CTLs are routinely found in healthy seropositive
patients (21). CMV enteritis and colitis are frequently observed
in immunocompromized patients with severe depletion of
CD4+ T cells (6–15). CMV colitis has also been described in
immunocompetent patients (124–25). However, these patients
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FIGURE 2 | CD4 Treg and CD8 Treg. Flow cytograph for CD4 Treg (A) and CD8Treg (C) in the patient and a simultaneously-analyzed healthy control. Individual data
from 10 healthy controls and the patient for CD4 Treg (B) and CD8 Treg (D) are shown. CD4+ Treg and CD8+ Treg are decreased in the patient.
FIGURE 3 | Granzyme B+, Perforin+, and PD-1+ CD8+ T cells. (A) shows a flow cytograph for 107a+, granzyme B+, and perforin + CD8+ T cells. (B) shows
individual data from 5 healthy control subjects and the patient. (C) shows a flow cytograph of PD-1+CD8+ T cells in the patient and a simultaneously-analyzed
healthy control. (D) show individual data of PD-1+ CD8+ T cells in 10 healthy controls and the patient. Granzyme B+, CD107a+, Perforin +, and PD-1+ CD8+ T
cells are increased in the patient.
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FIGURE 4 | CMV-specific tetramer+ CD8+ T cells at day 1 and 4 following
activation with anti-CD3/CD28 antibody. (A) show a flow cytograph of the
patient and simultaneously studied healthy control, and (B) shows individual
data from 5 healthy controls and the patient. CMV-specific tetramer + CD8+ T
cells are decreased in the patient.
may not be immunocompetent. Majority of these patients had
comorbidities that may be associated with immune dysfunctions
including diabetes mellitus, cirrhosis of liver, end-stage renal
disease, respiratory failure for which they were admitted
to ICU, and untreated non-hematological malignancies. No
immunological data were reported in these studies. CMV
infection of gastrointestinal tract in primary antibody deficiency
diseases is infrequent. The majority of reported cases of CMV
colitis in primary antibody deficiency disorders have been limited
to patients with common variable immunodeficiency (CVID) (6–
15). However, in these patients either CD4+ T cell numbers
were low or not reported. In none of these studies detailed
immunological analyses were performed. In immunosuppressed
patients who are susceptible to CMV reactivation the specific
to CMV epitope pp65 CD8 repertoire is limited. However, our
patient has no evidence of immunosuppression. Our patient
had normal number of CD3+T, CD4+T, NK, B cells, and
CD8+T cells were increased. He also responded normally to
mitogens and recall antigens, suggesting normal T cell functions.
Our patient has CMV-specific CD8+ T cell functional defect
(lacunar immunodeficiency).
T cells have been further classified into naïve (TN), central
memory (TCM), effector memory (TEM), and terminally
differentiated effector memory (TEMRA), and have been
characterized extensively for phenotype and functions (16–
18, 22). Naïve T cells (TN) upon exposure to virus undergo a
clonal expansion of effector cells, which after clearance of viral
antigens undergo a phase of contraction when antigen-specific
T cells undergo apoptosis, and a small number of antigen-
specific T cells are retained as memory T cells. These memory
T cells differentially express adhesion molecules and chemokine
receptors, which allow them to migrate and home in peripheral
blood lymphoid (central memory, TCM), or extralymphoid
tissues (effector memory, TEM). A small subpopulation of TEM
cells that re-acquires CD45RA are termed as TEMRA or terminally
differentiated memory cells. TEM and TEMRA T cells display poor
proliferation, decreased telomere length, resistance to apoptosis,
and express greater granzyme and perforin as compared to TN
and TCM. Perforin, a cytolytic protein, and granzyme B (GrB),
a serine protease, are found in granules in cytotoxic T-cells and
natural killer cells. Together they help mediate apoptosis in
targeted cells, including virus-infected target cells (23). In our
patient, CD8+ TEM cells are increased which would be consistent
with increased granzyme B+, and perforin+ CD8+ T cells.
Programmed cell death protein 1, or PD-1, functions as
an immune checkpoint and is found on exhausted T-cells
(24). Sester et al. (25) showed that in a population of renal
transplant recipients, CMV replication was associated with
higher expression of PD-1 in CMV-specific T cells. Dirks et al.
(26) observed that high PD-1 expressing CMV-specific T cells
proliferate poorly. Our patient also has increased PD-1+ CD8+
T cells. This would suggest that CD8+ CTL have expanded in
response to CMV infection; however, in doing so they appear to
be exhausted (PD-1+), and therefore, resulting in the persistence
of CMV.
Lamba et al. (27) studied the incidence and recurrence of
CMV infection in the patients who received reduced intensity
conditioning for allogeneic stem cell transplantation. Those
patients who failed to generate a CMV-specific CTL response
went on to develop CMV infection; one of these patients
developed CMV colitis. Cummins et al. (28) also found decreased
or absent CMV-specific T cells in two patients with late onset
CMV disease after organ transplantation; both of these patients
also presented with colitis. In our patient, CMV-specific CD8+
T cells were also reduced. Therefore, CMV-specific CD8+ T cell
deficiency may predispose patients with antibody deficiency with
normal T cell and T cell subsets, and NK cells to the development
of CMV colitis.
CD4+ T regulatory cells (Treg) suppress the activity of CMV-
pp65-specific CD8+ T cells, as measured by IFN-γ production
(29). In our patient CD4+ Treg were decreased. Therefore,
alteration in CD4 Treg in our patient is unlikely to be responsible
for decreased CMV-specific CD8+ T cells. We also observed
decreased CD8+ Treg in our patient. A role of CD8+ Treg
in regulating CMV-specific effector response, however, has not
been explored.
CONCLUDING REMARKS
A deficiency of CMV-specific cytotoxic CD8+ T cells may
predispose patients with antibody deficiency and normal
numbers of CD4+ T cells and functions to CMV colitis.
Furthermore, an expansion of PD-1+ exhausted CD8+ T cells
may play a role in the persistence of CMV infection. The
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mechanism (s) for deficiency of CMV-specific CD8+ T cells
remains unclear. Therefore, patients with antibody deficiency
and CMV c CMV-specific CD8+ T cells.
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